Testing effectiveness (Phase 2)Study completedNCT00023621
What this trial is testing
Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
Who this might be right for
Non-melanomatous Skin Cancer
University of California, San Francisco 60